Form 4: Verastem CFO Daniel Calkins Reports Acquisition and Sale of Common Stock

Daniel Calkins, CFO of Verastem, Inc., reports the acquisition of 38,850 shares of common stock through restricted stock units and the sale of 67 shares to cover withholding requirements.

Summary

• On June 18, 2024, Daniel Calkins, the Chief Financial Officer of Verastem, Inc., acquired 38,850 shares of common stock through restricted stock units (RSUs).
• These RSUs were granted under the company's Amended and Restated 2021 Equity Incentive Plan.
• The RSUs vest in three equal installments on the anniversaries of June 18, 2024, with full vesting by June 18, 2027, contingent upon continued employment.
• On June 20, 2024, Calkins sold 67 shares of common stock at a price of $3.16 per share.
• This sale was to satisfy statutory withholding requirements related to the vesting of the RSUs.
• Following these transactions, Calkins directly owns 47,318 shares of Verastem common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive, with no inherently positive or negative implications for the company's performance.

Positives

• The grant of RSUs to the CFO aligns his interests with those of the shareholders, incentivizing him to contribute to the company's long-term success.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings provide transparency to the market.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they involve a small number of shares and are related to executive compensation and tax obligations.

Key Dates